Plasma cell-free DNA (cfDNA) is derived from cellular death in various tissues. Investigating the tissue origin of cfDNA through cell type deconvolution, we can detect changes in tissue homeostasis that occur during disease progression or in response to treatment. Consequently, cfDNA has emerged as a valuable noninvasive biomarker for disease detection and treatment monitoring. Although there are many methylation-based methods for cfDNA cell type deconvolution, a comprehensive and systematic evaluation of these methods has yet to be conducted.

Methylation-based cell type deconvolution methods for plasma cell-free DNA can detect changes in tissue homeostasis during disease progression or treatment response, but a comprehensive and systematic evaluation is needed.

Paper

Systematic evaluation of methylation-based cell type deconvolution methods for plasma cell-free DNA

References

Citations